logo
Select company
Select metric
$ 188.59MNet Cash Flow - Financing
VS
Market
12
Sector
8
Industry
11
History
10
$ 18.81Close
$ 7.38 - $ 61.57 52-Week Range
Ticker Information

Ticker

TNXP

Company Name

TONIX PHARMACEUTICALS HOLDING CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TONIX PHARMACEUTICALS HOLDING CORP - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNXP - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 188.59M
3/31/2025$ 184.62M
12/31/2024$ 134.87M
9/30/2024$ 90.43M
6/30/2024$ 53.8M
3/31/2024$ 47.8M
12/31/2023$ 36.52M
9/30/2023$ 3.03M
6/30/2023$ -7.87M
3/31/2023$ 63.28M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TONIX PHARMACEUTICALS HOLDING CORP's latest trailing twelve months (TTM) CF - Financing stands at $ 91.19M.
  • Over the past 5 years, TONIX PHARMACEUTICALS HOLDING CORP's average CF - Financing has been $ 116.01M.
  • The median CF - Financing for TONIX PHARMACEUTICALS HOLDING CORP during this period was $ 119.97M
  • TONIX PHARMACEUTICALS HOLDING CORP reached its highest CF - Financing over the past 5 years at $ 212.49M.
  • The lowest CF - Financing recorded by TONIX PHARMACEUTICALS HOLDING CORP in the same timeframe $ -7.87M

TONIX PHARMACEUTICALS HOLDING CORP's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
PRTA : PROTHENA CORP PUBLIC LTD CO $ 152KCAPR : CAPRICOR THERAPEUTICS INC $ 148.48MLCTX : LINEAGE CELL THERAPEUTICS INC $ 26.47MRLAY : RELAY THERAPEUTICS INC $ 220.34MABSI : ABSCI CORP $ 43.27MPRME : PRIME MEDICINE INC $ 44.71MTVRD : TVARDI THERAPEUTICS INC $ 20.71MOCGN : OCUGEN INC $ 63.77MFATE : FATE THERAPEUTICS INC $ 4.46MSRZN : SURROZEN INC $ 71.35M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

TNXP - Net Cash Flow - Financing, Last 5 years

$ -7.87M

Minimum

Jun 30, 2023

$ 212.49M

Maximum

Dec 31, 2021

$ 116.01M

Average

$ 119.97M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.89M with a standard deviation of $ 118.55M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -365.75M
max$ 365M
average$ -6.89M
median$ 314K
std$ 118.55M